Evidence map›Paper›PMID 26949223›Full record

ReviewCurrent allergy and asthma reports2016

Diagnosis and Management of Rhinosinusitis: Highlights from the 2015 Practice Parameter.

Kathleen Dass, Anju Tripathi Peters

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current allergy and asthma reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Cyclamen europaeum extract for acute sinusitis.The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Definition and management of odontogenic maxillary sinusitis.Maxillofacial plastic and reconstructive surgery · 2019
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kathleen DassDepartment of Allergy and Immunology, Northwestern University Feinberg School of Medicine, 211 E. Ontario Street, Ste. 1000, Chicago, IL, 60611, USA. Kathleen.Dass@northwestern.edu.
Anju Tripathi PetersDepartment of Allergy and Immunology, Northwestern University Feinberg School of Medicine, 211 E. Ontario Street, Ste. 1000, Chicago, IL, 60611, USA. anjupeters@northwestern.edu.
Northwestern University · US

Funding

Systems Genetics Approach to Gene Discovery in Chronic RhinosinusitisU19AI106683 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHLEIMER, ROBERT P · 2014 to 2017
$7.9M
NIAID NIH HHS U19-AI106683
6 · The paper itself

Abstract

Rhinosinusitis is a commonly diagnosed disease in the USA. Rhinosinusitis is classified as acute, recurrent, or chronic (with or without nasal polyps). While acute rhinosinusitis is diagnosed by history and physical examination, chronic rhinosinusitis and recurrent acute rhinosinusitis are diagnosed based on symptoms and the presence of disease on either a sinus CT scan and/or endoscopy. Management of uncomplicated acute rhinosinusitis includes analgesics, saline irrigation, and/or intranasal steroids. Antibiotics and intranasal steroids are recommended for acute bacterial rhinosinusitis. Intranasal and oral steroids with antibiotics are recommended to treat chronic rhinosinusitis although the evidence for antibiotics is weak. Biologics such as omalizumab and mepolizumab are being investigated for the treatment of chronic rhinosinusitis with nasal polyps. Surgery may be indicated in management of refractory chronic rhinosinusitis and rarely for acute bacterial rhinosinusitis. This review discusses highlights of the updated 2014 practice parameter and up-to-date evidence from other literature sources.

Indexed as

Acute DiseaseAnti-Bacterial AgentsAntibodies, Monoclonal, HumanizedBacterial InfectionsChronic DiseaseEndoscopyGlucocorticoidsHumansOmalizumabRhinitisSinusitisTomography, X-Ray ComputedAnti-Bacterial AgentsAntibodies, Monoclonal, HumanizedGlucocorticoidsmepolizumabOmalizumabAcute bacterial rhinosinusitisAcute rhinosinusitisAntibiotic therapyBiologic therapyChronic rhinosinusitisNasal polyps

Identifiers

PMID26949223
OpenAlexW2298454374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.